Selective Inhibitors of Pancreatic Cholesterol Esterase
Selective Inhibitors of Pancreatic Cholesterol Esterase
批准号:
6337793
负责人:
John E. Heidrich
金额:
$7.03万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2001-11-30
关键词:
acetylcholinesterase antihypercholesterolemic agent clinical chemistry dietary lipid dosage drug adverse effect drug design /synthesis /production enzyme inhibitors gastrointestinal absorption /transport hamsters histopathology lipid metabolism nonhuman therapy evaluation nutrition related tag pancreas enzyme serology /serodiagnosis urinalysis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Scanned from the Applicant's Abstract): The specific aim of this
esterase (CE) inhibitor in an acute cholesterol absorption assay. Hamsters will
be gavage fed 3H-labeled cholesterol with CE-inhibitor ranging from 20-200
umoles. Twenty-four hours later, hepatic and serum cholesterol absorption will
be assayed. Hepatic and serum cholesterol levels will be determined in a
subchronic hamster assay. CE-inhibitor from 20-200 umoles will be fed in chow
supplemented with 0.2 percent cholesterol and 0.1 percent cholic acid for 4
days. Hepatic and serum cholesterol will be determined. In a third study,
toxicity will be determined following a 30 day feeding trial of CE inhibitor.
The optimum dose of CE-inhibitor determined in the previous two experiments and
200 umoles will be added to chow supplemented with 1 percent cholesterol and 0.5
percent cholic acid. Clinical chemistry, hepatic and serum cholesterol,
urinalysis and histopathology will be obtained.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1186/1471-2210-4-5
发表时间:
2004-04-19
期刊:
BMC pharmacology
影响因子:
--
作者:
[Heidrich JE, Contos LM, Hunsaker LA, Deck LM, Vander Jagt DL]
通讯作者:
Vander Jagt DL
DEVELOPMENT OF NEW ANTI-FELINE LEUKEMIA VIRUS DRUGS
-
批准号:3489639
-
项目类别:
-
资助金额:$4.4万
-
财政年份:1992
-
负责人:John E. Heidrich
-
依托单位: